Sign in / Join Now
ETFs & Funds
I feel like the reaction to the news was too intense and expect a pullback. 800 million market cap is an overvaluation.
Add a reply...
Latest StockTalks »
people get OMED breaking news and analysis by email alert.
Get email alerts on OMED »
OncoMed Pharmaceuticals, Inc
Get latest price
From other sites
OncoMed Pharmaceuticals To Report Financial Results For The Third Quarter On Tuesday, November 1, 2016
at TheStreet (Wed, 8:30AM)
OncoMed Presents Interim Phase 1b Data For Ipafricept And Vantictumab In Pancreatic Cancer At The ESMO 2016 Congress
at TheStreet (Oct 10, 2016)
Noteworthy Friday Option Activity: OMED, HLF, CIA
at TheStreet (Sep 30, 2016)
OncoMed To Present Clinical Data For Wnt Inhibitors At The ESMO 2016 Congress
at TheStreet (Sep 29, 2016)
HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target
at Benzinga (Sep 22, 2016)